Logo image of CD

CHINDATA GROUP HOLDINGS-ADR (CD) Stock Fundamental Analysis

USA - NASDAQ:CD - US16955F1075 - ADR

8.45 USD
-0.14 (-1.63%)
Last: 12/18/2023, 8:00:02 PM
8.56 USD
+0.11 (+1.3%)
After Hours: 12/18/2023, 8:00:02 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CD. CD was compared to 86 industry peers in the IT Services industry. While CD is still in line with the averages on profitability rating, there are concerns on its financial health. CD is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CD was profitable.
CD had a positive operating cash flow in the past year.
In multiple years CD reported negative net income over the last 5 years.
CD had a positive operating cash flow in 4 of the past 5 years.
CD Yearly Net Income VS EBIT VS OCF VS FCFCD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 1B -1B -2B -3B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.12%, CD is in line with its industry, outperforming 59.30% of the companies in the same industry.
CD has a Return On Equity of 7.36%. This is comparable to the rest of the industry: CD outperforms 59.30% of its industry peers.
With a Return On Invested Capital value of 4.63%, CD perfoms like the industry average, outperforming 55.81% of the companies in the same industry.
CD had an Average Return On Invested Capital over the past 3 years of 2.48%. This is significantly below the industry average of 21.41%.
The last Return On Invested Capital (4.63%) for CD is above the 3 year average (2.48%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.12%
ROE 7.36%
ROIC 4.63%
ROA(3y)0.92%
ROA(5y)-1.87%
ROE(3y)2.06%
ROE(5y)-3.93%
ROIC(3y)2.48%
ROIC(5y)N/A
CD Yearly ROA, ROE, ROICCD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 5 -5 -10 -15 -20

1.3 Margins

Looking at the Profit Margin, with a value of 14.84%, CD belongs to the top of the industry, outperforming 91.86% of the companies in the same industry.
Looking at the Operating Margin, with a value of 27.33%, CD belongs to the top of the industry, outperforming 97.67% of the companies in the same industry.
The Gross Margin of CD (41.17%) is better than 66.28% of its industry peers.
In the last couple of years the Gross Margin of CD has grown nicely.
Industry RankSector Rank
OM 27.33%
PM (TTM) 14.84%
GM 41.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.47%
GM growth 5YN/A
CD Yearly Profit, Operating, Gross MarginsCD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 -50 -100

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CD is destroying value.
CD has more shares outstanding than it did 1 year ago.
CD has a worse debt/assets ratio than last year.
CD Yearly Shares OutstandingCD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 100M 200M 300M
CD Yearly Total Debt VS Total AssetsCD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 1.49, we must say that CD is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CD (1.49) is worse than 61.63% of its industry peers.
A Debt/Equity ratio of 0.92 indicates that CD is somewhat dependend on debt financing.
The Debt to Equity ratio of CD (0.92) is worse than 66.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z 1.49
ROIC/WACC0.48
WACC9.67%
CD Yearly LT Debt VS Equity VS FCFCD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 5B 10B

2.3 Liquidity

CD has a Current Ratio of 1.99. This is a normal value and indicates that CD is financially healthy and should not expect problems in meeting its short term obligations.
CD's Current ratio of 1.99 is fine compared to the rest of the industry. CD outperforms 62.79% of its industry peers.
A Quick Ratio of 1.99 indicates that CD should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.99, CD is doing good in the industry, outperforming 63.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.99
CD Yearly Current Assets VS Current LiabilitesCD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2B 4B 6B

More info and screens

8

3. Growth

3.1 Past

CD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.42%, which is quite impressive.
Looking at the last year, CD shows a very strong growth in Revenue. The Revenue has grown by 60.59%.
The Revenue has been growing by 74.75% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)116.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.87%
Revenue 1Y (TTM)60.59%
Revenue growth 3Y74.75%
Revenue growth 5YN/A
Sales Q2Q%49.68%

3.2 Future

The Earnings Per Share is expected to grow by 19.02% on average over the next years. This is quite good.
The Revenue is expected to grow by 22.00% on average over the next years. This is a very strong growth
EPS Next Y0.59%
EPS Next 2Y24.1%
EPS Next 3Y27.24%
EPS Next 5Y19.02%
Revenue Next Year40.45%
Revenue Next 2Y31.47%
Revenue Next 3Y28.29%
Revenue Next 5Y22%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CD Yearly Revenue VS EstimatesCD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
CD Yearly EPS VS EstimatesCD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.61 indicates a rather expensive valuation of CD.
66.28% of the companies in the same industry are more expensive than CD, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CD to the average of the S&P500 Index (26.91), we can say CD is valued slightly cheaper.
CD is valuated rather expensively with a Price/Forward Earnings ratio of 18.21.
CD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CD is cheaper than 70.93% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CD to the average of the S&P500 Index (22.92), we can say CD is valued slightly cheaper.
Industry RankSector Rank
PE 20.61
Fwd PE 18.21
CD Price Earnings VS Forward Price EarningsCD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CD is cheaper than 69.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.91
CD Per share dataCD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CD's earnings are expected to grow with 27.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)34.73
PEG (5Y)N/A
EPS Next 2Y24.1%
EPS Next 3Y27.24%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHINDATA GROUP HOLDINGS-ADR

NASDAQ:CD (12/18/2023, 8:00:02 PM)

After market: 8.56 +0.11 (+1.3%)

8.45

-0.14 (-1.63%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-20 2023-11-20/bmo
Earnings (Next)03-13 2024-03-13/amc
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.10B
Revenue(TTM)5.59B
Net Income(TTM)829.70M
Analysts82.86
Price Target11.36 (34.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)122.13%
Min EPS beat(2)76.75%
Max EPS beat(2)167.5%
EPS beat(4)4
Avg EPS beat(4)89.95%
Min EPS beat(4)13.15%
Max EPS beat(4)167.5%
EPS beat(8)8
Avg EPS beat(8)192.85%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.39%
Min Revenue beat(2)0.5%
Max Revenue beat(2)10.28%
Revenue beat(4)4
Avg Revenue beat(4)6.1%
Min Revenue beat(4)0.5%
Max Revenue beat(4)10.28%
Revenue beat(8)7
Avg Revenue beat(8)3.7%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.12%
EPS NY rev (1m)0%
EPS NY rev (3m)54.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)98760.2%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 20.61
Fwd PE 18.21
P/S 3.94
P/FCF N/A
P/OCF 10.5
P/B 1.95
P/tB 2.09
EV/EBITDA 10.91
EPS(TTM)0.41
EY4.85%
EPS(NY)0.46
Fwd EY5.49%
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)0.8
OCFY9.52%
SpS2.15
BVpS4.33
TBVpS4.03
PEG (NY)34.73
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.12%
ROE 7.36%
ROCE 6.8%
ROIC 4.63%
ROICexc 5.92%
ROICexgc 6.19%
OM 27.33%
PM (TTM) 14.84%
GM 41.17%
FCFM N/A
ROA(3y)0.92%
ROA(5y)-1.87%
ROE(3y)2.06%
ROE(5y)-3.93%
ROIC(3y)2.48%
ROIC(5y)N/A
ROICexc(3y)3.27%
ROICexc(5y)N/A
ROICexgc(3y)3.49%
ROICexgc(5y)N/A
ROCE(3y)3.73%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.47%
GM growth 5YN/A
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA 3.94
Cap/Depr 480.52%
Cap/Sales 95.88%
Interest Coverage 250
Cash Conversion 79.28%
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.99
Altman-Z 1.49
F-Score5
WACC9.67%
ROIC/WACC0.48
Cap/Depr(3y)606.68%
Cap/Depr(5y)737.01%
Cap/Sales(3y)125.95%
Cap/Sales(5y)327.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.87%
EPS Next Y0.59%
EPS Next 2Y24.1%
EPS Next 3Y27.24%
EPS Next 5Y19.02%
Revenue 1Y (TTM)60.59%
Revenue growth 3Y74.75%
Revenue growth 5YN/A
Sales Q2Q%49.68%
Revenue Next Year40.45%
Revenue Next 2Y31.47%
Revenue Next 3Y28.29%
Revenue Next 5Y22%
EBIT growth 1Y57.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year152.3%
EBIT Next 3Y56.96%
EBIT Next 5Y40.16%
FCF growth 1Y-46.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y150.74%
OCF growth 3Y177.53%
OCF growth 5YN/A

CHINDATA GROUP HOLDINGS-ADR / CD FAQ

What is the fundamental rating for CD stock?

ChartMill assigns a fundamental rating of 4 / 10 to CD.


What is the valuation status of CHINDATA GROUP HOLDINGS-ADR (CD) stock?

ChartMill assigns a valuation rating of 3 / 10 to CHINDATA GROUP HOLDINGS-ADR (CD). This can be considered as Overvalued.


Can you provide the profitability details for CHINDATA GROUP HOLDINGS-ADR?

CHINDATA GROUP HOLDINGS-ADR (CD) has a profitability rating of 5 / 10.


What is the financial health of CHINDATA GROUP HOLDINGS-ADR (CD) stock?

The financial health rating of CHINDATA GROUP HOLDINGS-ADR (CD) is 2 / 10.